|
Rapid Micro Biosystems, Inc. (RPID) DCF Valuation
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Rapid Micro Biosystems, Inc. (RPID) Bundle
Maximize efficiency and improve precision with our Rapid Micro Biosystems, Inc. (RPID) DCF Calculator! Utilizing real data from Rapid Micro Biosystems and adjustable assumptions, this tool empowers you to forecast, analyze, and value Rapid Micro Biosystems, Inc. like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.5 | 16.1 | 23.2 | 17.1 | 22.5 | 25.2 | 28.1 | 31.4 | 35.1 | 39.3 |
| Revenue Growth, % | 0 | -2.63 | 44.5 | -26.25 | 31.44 | 11.76 | 11.76 | 11.76 | 11.76 | 11.76 |
| EBITDA | -16.9 | -32.0 | -45.8 | -60.4 | -53.8 | -25.2 | -28.1 | -31.4 | -35.1 | -39.3 |
| EBITDA, % | -102.16 | -199.02 | -197.15 | -352.43 | -238.72 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.5 | 1.5 | 1.6 | 4.0 | 3.1 | 3.1 | 3.5 | 3.9 | 4.4 | 4.9 |
| Depreciation, % | 9.08 | 9.33 | 7.01 | 23.23 | 13.79 | 12.49 | 12.49 | 12.49 | 12.49 | 12.49 |
| EBIT | -18.4 | -33.5 | -47.4 | -64.4 | -56.9 | -25.2 | -28.1 | -31.4 | -35.1 | -39.3 |
| EBIT, % | -111.25 | -208.35 | -204.17 | -375.66 | -252.51 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 12.5 | 45.1 | 193.5 | 108.6 | 92.1 | 23.9 | 26.7 | 29.9 | 33.4 | 37.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.9 | 5.8 | 5.4 | 5.5 | 5.6 | 7.3 | 8.2 | 9.2 | 10.2 | 11.5 |
| Account Receivables, % | 29.79 | 35.98 | 23.25 | 31.99 | 24.79 | 29.16 | 29.16 | 29.16 | 29.16 | 29.16 |
| Inventories | 5.8 | 9.0 | 15.7 | 21.2 | 20.0 | 17.5 | 19.5 | 21.8 | 24.4 | 27.2 |
| Inventories, % | 34.84 | 55.76 | 67.45 | 123.66 | 88.64 | 69.34 | 69.34 | 69.34 | 69.34 | 69.34 |
| Accounts Payable | 3.2 | 4.5 | 3.9 | 5.4 | 2.0 | 5.3 | 5.9 | 6.6 | 7.4 | 8.2 |
| Accounts Payable, % | 19.45 | 27.79 | 16.98 | 31.68 | 8.76 | 20.93 | 20.93 | 20.93 | 20.93 | 20.93 |
| Capital Expenditure | -1.7 | -.7 | -3.2 | -6.7 | -1.8 | -3.8 | -4.3 | -4.8 | -5.3 | -6.0 |
| Capital Expenditure, % | -10.27 | -4.29 | -13.85 | -39.34 | -8.19 | -15.19 | -15.19 | -15.19 | -15.19 | -15.19 |
| Tax Rate, % | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 | -0.05911969 |
| EBITAT | -18.7 | -33.6 | -47.5 | -63.8 | -56.9 | -25.1 | -28.1 | -31.4 | -35.1 | -39.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -26.4 | -35.6 | -55.9 | -70.6 | -58.0 | -21.8 | -31.1 | -34.8 | -38.9 | -43.5 |
| WACC, % | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 | 8.77 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -129.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -44 | |||||||||
| Terminal Value | -655 | |||||||||
| Present Terminal Value | -430 | |||||||||
| Enterprise Value | -560 | |||||||||
| Net Debt | -17 | |||||||||
| Equity Value | -543 | |||||||||
| Diluted Shares Outstanding, MM | 43 | |||||||||
| Equity Value Per Share | -12.61 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real RPID financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on Rapid Micro Biosystems’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life RPID Financials: Pre-filled historical and projected data for Rapid Micro Biosystems, Inc. (RPID).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Rapid Micro Biosystems’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Rapid Micro Biosystems’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Rapid Micro Biosystems, Inc. (RPID).
- Step 2: Review the pre-filled financial data and forecasts for Rapid Micro Biosystems.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Rapid Micro Biosystems, Inc. (RPID)?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for RPID.
- Adjustable Parameters: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes RPID’s intrinsic value and Net Present Value.
- Preloaded Information: Access historical and projected data for precise evaluations.
- Expert-Level Tool: Perfect for financial analysts, investors, and business advisors focusing on RPID.
Who Should Use This Product?
- Healthcare Professionals: Implement advanced technologies for microbial detection and monitoring.
- Laboratory Managers: Optimize workflow and enhance accuracy in microbial testing processes.
- Investors: Evaluate the growth potential of Rapid Micro Biosystems, Inc. (RPID) in the biotech sector.
- Researchers and Academics: Leverage innovative methodologies for studies in microbiology and diagnostics.
- Quality Assurance Teams: Ensure compliance and reliability in microbial quality control procedures.
What the Template Contains
- Pre-Filled Data: Includes Rapid Micro Biosystems, Inc.'s (RPID) historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations tailored for (RPID).
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs specific to (RPID).
- Key Financial Ratios: Analyze Rapid Micro Biosystems, Inc.'s (RPID) profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease for (RPID).
- Clear Dashboard: Charts and tables summarizing key valuation results for Rapid Micro Biosystems, Inc. (RPID).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.